Publications in collaboration with researchers from Universidade de Vigo (62)

2022

  1. Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs

    Cancers, Vol. 14, Núm. 19

2020

  1. Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial

    Scientific Reports, Vol. 10, Núm. 1

  2. Value of serum NEUROG1 methylation for the detection of advanced adenomas and colorectal cancer

    Diagnostics, Vol. 10, Núm. 7

2018

  1. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples

    Clinical Epigenetics, Vol. 10, Núm. 1

2017

  1. A simple electroelution method for rapid protein purification: Isolation and antibody production of alpha toxin from Clostridium septicum

    PeerJ, Vol. 2017, Núm. 6

  2. Evaluation of an automated commercial ELISA method for calprotectin determination in pleural fluid

    Clinical Chemistry and Laboratory Medicine

  3. Highly sensitive marker panel for guidance in lung cancer rapid diagnostic units

    Scientific Reports, Vol. 7

  4. Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis

    BMC Cancer, Vol. 17, Núm. 1

2016

  1. Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer

    Scientific Reports, Vol. 6

2015

  1. Aplicación de la proteómica en la búsqueda de nuevos marcadores tumorales para el cáncer colorrectal

    Abordaje multidisciplinar de cáncer colorrectal (Andavira), pp. 533-547

  2. Pretreatment levels of the serum biomarkers CEA, CYFRA 21–1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients

    SpringerPlus, Vol. 4, Núm. 1

  3. Serum calprotectin, CD26 and EGF to establish a panel for the diagnosis of lung cancer

    PLoS ONE, Vol. 10, Núm. 5

  4. Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening

    Scientific Reports, Vol. 5

  5. Serum sCD26 for colorectal cancer screening in family-risk individuals: Comparison with faecal immunochemical test

    British Journal of Cancer, Vol. 112, Núm. 2, pp. 375-381

2014

  1. Evaluation of pleural effusion sCD26 and DPP-IV as diagnostic biomarkers in lung disease

    Scientific Reports, Vol. 4

  2. Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients

    PLoS ONE, Vol. 9, Núm. 9

  3. Proteomics for discovery of candidate colorectal cancer biomarkers

    World Journal of Gastroenterology, Vol. 20, Núm. 14, pp. 3804-3824

2013

  1. Decreased expression of alpha-L-fucosidase gene FUCA1 in human colorectal tumors

    International Journal of Molecular Sciences, Vol. 14, Núm. 8, pp. 16986-16998

  2. Levels of PEDF in pleural effusions from lung adenocarcinoma and benign disease patients

    Disease Markers, Vol. 34, Núm. 6, pp. 425-430

  3. Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer

    BMC Cancer, Vol. 13